rs11709323
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006218.4(PIK3CA):c.-76-19T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0124 in 634,656 control chromosomes in the GnomAD database, including 298 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0088 ( 42 hom., cov: 32)
Exomes 𝑓: 0.014 ( 256 hom. )
Consequence
PIK3CA
NM_006218.4 intron
NM_006218.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.27
Publications
3 publications found
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
PIK3CA Gene-Disease associations (from GenCC):
- overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- megalencephaly-capillary malformation-polymicrogyria syndromeInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- vascular malformationInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden syndrome 5Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 3-179198731-T-C is Benign according to our data. Variant chr3-179198731-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 1181592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00882 AC: 1343AN: 152198Hom.: 42 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1343
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0136 AC: 6555AN: 482340Hom.: 256 Cov.: 6 AF XY: 0.0133 AC XY: 3320AN XY: 249972 show subpopulations
GnomAD4 exome
AF:
AC:
6555
AN:
482340
Hom.:
Cov.:
6
AF XY:
AC XY:
3320
AN XY:
249972
show subpopulations
African (AFR)
AF:
AC:
19
AN:
12934
American (AMR)
AF:
AC:
40
AN:
13944
Ashkenazi Jewish (ASJ)
AF:
AC:
28
AN:
13114
East Asian (EAS)
AF:
AC:
3651
AN:
30606
South Asian (SAS)
AF:
AC:
180
AN:
34344
European-Finnish (FIN)
AF:
AC:
110
AN:
43478
Middle Eastern (MID)
AF:
AC:
7
AN:
3552
European-Non Finnish (NFE)
AF:
AC:
2269
AN:
304048
Other (OTH)
AF:
AC:
251
AN:
26320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
323
646
968
1291
1614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00879 AC: 1339AN: 152316Hom.: 42 Cov.: 32 AF XY: 0.00934 AC XY: 696AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
1339
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
696
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
75
AN:
41578
American (AMR)
AF:
AC:
74
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
3472
East Asian (EAS)
AF:
AC:
608
AN:
5190
South Asian (SAS)
AF:
AC:
42
AN:
4832
European-Finnish (FIN)
AF:
AC:
21
AN:
10620
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
502
AN:
68008
Other (OTH)
AF:
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
67
133
200
266
333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
125
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Sep 04, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.